GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bridge Biotherapeutics Inc (XKRX:288330) » Definitions » Cash Flow for Lease Financing

Bridge Biotherapeutics (XKRX:288330) Cash Flow for Lease Financing : ₩-461.12 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Bridge Biotherapeutics Cash Flow for Lease Financing?

Bridge Biotherapeutics's Cash Flow for Lease Financing for the three months ended in Mar. 2025 was ₩-100.28 Mil. Bridge Biotherapeutics's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-461.12 Mil.

Compared with last quarter (₩-101.58 Mil in Dec. 2024 ), Bridge Biotherapeutics's Cash Flow for Lease Financing increased in Mar. 2025 (₩-100.28 Mil).

Bridge Biotherapeutics Cash Flow for Lease Financing Historical Data

The historical data trend for Bridge Biotherapeutics's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bridge Biotherapeutics Cash Flow for Lease Financing Chart

Bridge Biotherapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only -176.04 -168.14 -763.67 -1,023.81 -618.47

Bridge Biotherapeutics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -257.63 -273.19 13.93 -101.58 -100.28

Bridge Biotherapeutics Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-461.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bridge Biotherapeutics Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Bridge Biotherapeutics's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Bridge Biotherapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bridge Biotherapeutics Inc (XKRX:288330) » Definitions » Cash Flow for Lease Financing
Comparable Companies
XKRX:036480 XKRX:950220 XKRX:291650 XKRX:432980 XKRX:284620 XKRX:215380 XKRX:199730 XKRX:344860 XKRX:343090 XKRX:373110 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
58, Pangyo - ro, Gyeonggi No. 303, 255 beongil Seas Tower in Bundang Pangyo, Seongnam-si, KOR, 13486
Website
http://www.bridgebiorx.com
Bridge Biotherapeutics Inc is a drug research and development company. It operates in the pharmaceutical and bio industry. The company has two pipeline clinical-stage products namely, BBT-401 and BBT-877.

Bridge Biotherapeutics Headlines

No Headlines